"INOVATIVNA TERAPIJA, KLINIČKA ISPITIVANJA, KLINIČKI ISTRAŽIVAČKI CENTAR, ZNANSTVENI RADOVI, MEDICINSKO PISANJE I BIOSTATISTIKA. Misija SOLMED Grupe jest pružiti ono najbolje što biomedicinska znanost može ponuditi pacijentima, liječnicima i znanstvenicima. Otvaramo pacijentima nove mogućnosti primjene inovativne terapije koja je učinkovita, sigurna i besplatna. Nudimo platformu za liječnike i farmaceute koja im omogućuje sudjelovanje u kliničkim ispitivanjima, prilagođeno njihovim potrebama i mogućnostima. Naš tim renomiranih liječnika i znanstvenika nudi cjelovite usluge biostatistike, pisanja znanstvenih radova te edukaciju s područja znanstvenog rada i kliničkih ispitivanja."

During the past decade, Poliklinika Solmed conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Poliklinika Solmed" are "Crohn's Disease" (2 trials), "Colitis, Ulcerative" (1 trials), "Crohn Disease" (1 trials), "Relapsing Multiple Sclerosis" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Poliklinika Solmed" in a lesser frequency.

Most popular intervention types in "Poliklinika Solmed" are "Drug" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Guselkumab" (3 trials), "Golimumab" (2 trials), "Guselkumab Dose 1" (2 trials) and "Guselkumab Dose 2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Poliklinika Solmed" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Poliklinika Solmed". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Poliklinika Solmed, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Poliklinika Solmed, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".